CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Planned sale President sold 51,110 shares at $26.27 ($1,342,752)
- 4 Planned sale Chief Legal Officer sold 385 shares at $23.48 ($9,040)
- 4 Planned sale SVP, Finance and Treasurer sold 289 shares at $23.48 ($6,785)
- 4 Planned sale CEO sold 60,000 shares at $24.60 ($1,476,024)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 1,250 shares at an average $23.28 ($29,094)
- 4 Planned sale CEO sold 60,000 shares at $24.50 ($1,470,156)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 12,500 shares (grant or award)
- 4 Planned sale Chief Medical Officer sold 23,687 shares at an average $31.02 ($734,805)
- 4 Planned sale Chief Legal Officer sold 3,401 shares at $32.12 ($109,240)
- 4 Planned sale Chief Financial Officer sold 5,446 shares at $32.12 ($174,926)
- 4 Planned sale CEO sold 18,102 shares at $32.13 ($581,617)
- 4 Planned sale President sold 4,534 shares at $32.12 ($145,632)
Page 5 of 12 · 238 filings